Selection and Sequencing of Targeted Therapy for HR+/HER2- Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
How We Are Integrating New Findings Into Treatment for HER2-Positive Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Smarter. Stronger. Together: Achieving Quality HER2-Positive Breast Cancer Care by Educating Providers and Patients

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.50
Express PointsSmarter. Stronger. Together: Achieving Quality HER2-Positive Breast Cancer Care by Educating Providers and Patients

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Understanding HER2-Low Breast Cancer: Current Challenges and Emerging Opportunities for Treatment

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
PodcastPearls: Expert Insights on Optimal Use of CDK4/6 Inhibitors for HR-Positive/HER2-Negative Breast Cancer

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Expert Insights on Optimal Use of CDK4/6 Inhibitors for HR-Positive/HER2-Negative Breast Cancer

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Clinical Decision-Making for Patients With HR+ HER2- Early Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
ExpressPoints:Clinical Decision-Making for Patients With HR+ HER2- Early Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Neoadjuvant Therapy Considerations With CDK4/6 Inhibitors in HR+/HER2- EBC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Smarter. Stronger. Together: Educating Providers and Patients to Optimize the Use of Targeted Oral Therapies for HR+/HER2- Breast Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
CDK4/6 and PI3K Inhibitors for HR+/HER2- Breast Cancer in the Clinic Today: Thoughts From the Experts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
ExpressPoints: Educating Providers and Patients to Optimize the Use of Targeted Oral Therapies for HR+/HER2- Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Smarter. Stronger. Together: Educating Providers and Patients to Optimize the Use of Targeted Oral Therapies for HR+/HER2- Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
New Insights in Breast Cancer: Independent Conference Coverage of SABCS 2020

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.25
CCO Conference Highlights From the 2020 SABCS Virtual Symposium

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
A Look Ahead to the 2020 SABCS Virtual Symposium

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
MedicalMinute: Selecting Novel HER2- and TROP2-Targeted Therapeutics for Patients With Metastatic Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.25
New Targeted Therapies for HER2-Positive Metastatic Breast Cancer: Downloadable Slides

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Key Studies in Breast and Gynecologic Cancers: Independent Conference Coverage of the 2020 ASCO Virtual Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
ExpressPoints: Key Studies in Breast and Gynecologic Cancers

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Insights Into Sequencing Treatment and Overcoming Resistance in HR-Positive/HER2-Negative ABC

Content Format:

Video

Credit Type:

AMA

Credits:

1.25
ExpressPoints: Sequencing Treatment and Overcoming Resistance in HR-Positive/HER2-Negative ABC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
CDK4/6 Inhibitors for Premenopausal and Postmenopausal Women With HR-Positive/HER2-Negative Advanced Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
An Expert’s Guide to ASCO 2020: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
New Insights in Breast Cancer: Independent Conference Coverage of SABCS 2019

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
I’m Excited About New Agents for HER2+ Breast Cancer From SABCS 2019! Here’s Why.

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
A Look Ahead to the 2019 SABCS Meeting

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

0.25
CCO Conference Highlights of the ESMO 2019 Congress

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Preview of ESMO 2019: Key Expert-Selected Studies

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
An Evening With Experts: Selecting and Sequencing Therapy in HR+/HER2- Metastatic Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
Targeting the PI3K Pathway in HR+/HER2- MBC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
An Expert’s Guide to ASCO 2019: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Current Therapeutic Approaches for Early-Stage HER2-Positive Breast Cancer: Aligning Practice With Expert Consensus

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Treatment Options From 5 Experts on Neoadjuvant and Adjuvant Therapy for HER2-Positive Early Breast Cancer: An Online Tool

Content Format:

Tool

Credit Type:

--

Credits:

--